{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T21:59:44Z","timestamp":1794866384558,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["451-03-66\/2024-03\/200042"],"award-info":[{"award-number":["451-03-66\/2024-03\/200042"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RC 21\/17"],"award-info":[{"award-number":["RC 21\/17"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministry of Health","doi-asserted-by":"publisher","award":["RC 23\/23"],"award-info":[{"award-number":["RC 23\/23"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101059870"],"award-info":[{"award-number":["101059870"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.biopha.2025.117824","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T18:58:28Z","timestamp":1737140308000},"page":"117824","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease"],"prefix":"10.1016","volume":"183","author":[{"given":"Giulia","family":"Zudeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Selvestrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bramuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Cecchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biljana","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikola","family":"Kotur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branka","family":"Zukic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Dragasevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Decorti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Stocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Lucaf\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.117824_bib1","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front. Med."},{"issue":"2","key":"10.1016\/j.biopha.2025.117824_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J. Med. Life"},{"issue":"9","key":"10.1016\/j.biopha.2025.117824_bib3","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v17.i9.1095","article-title":"Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease","volume":"17","author":"De Iudicibus","year":"2011","journal-title":"World J. Gastroenterol."},{"issue":"12","key":"10.1016\/j.biopha.2025.117824_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/01.mib.0000235835.32176.85","article-title":"A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's disease and ulcerative colitis","volume":"12","author":"Tung","year":"2006","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.biopha.2025.117824_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.673068","article-title":"Gender May Influence the immunosuppressive actions of prednisone in young patients with inflammatory bowel disease","volume":"12","author":"Lucaf\u00f2","year":"2021","journal-title":"Front Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2025.117824_bib6","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000507","article-title":"Gender differences in prednisone adverse effects: survey result from the MG registry","volume":"5","author":"Lee","year":"2018","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"issue":"24","key":"10.1016\/j.biopha.2025.117824_bib7","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.2174\/0929867324666170920145337","article-title":"Pharmacotranscriptomic biomarkers in glucocorticoid treatment of pediatric inflammatory bowel disease","volume":"25","author":"Lucaf\u00f2","year":"2018","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.biopha.2025.117824_bib8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/cts.12961","article-title":"Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients","volume":"14","author":"Lucaf\u00f2","year":"2021","journal-title":"Clin. Transl. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2025.117824_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/ng.3283","article-title":"NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells","volume":"47","author":"Paugh","year":"2015","journal-title":"Nat. Genet"},{"issue":"13","key":"10.1016\/j.biopha.2025.117824_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133328","article-title":"The NLRP3 inflammasome: an overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.117824_bib11","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2019.00276","article-title":"NLRP3 inflammasome and inflammatory bowel disease","volume":"10","author":"Zhen","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2025.117824_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5152\/tjg.2023.22515","article-title":"Epigenetics of inflammatory bowel diseases","volume":"34","author":"T\u00f6r\u00fcner","year":"2023","journal-title":"Turk. J. Gastroenterol."},{"key":"10.1016\/j.biopha.2025.117824_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/4323281","article-title":"NLRP3 activation was regulated by DNA methylation modification during mycobacterium tuberculosis infection","volume":"2016","author":"Wei","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"33","key":"10.1016\/j.biopha.2025.117824_bib14","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.3748\/wjg.v25.i33.4796","article-title":"Role of NLRP3 inflammasome in inflammatory bowel diseases","volume":"25","author":"Tourkochristou","year":"2019","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2025.117824_bib15","first-page":"S9","article-title":"Inflammatory bowel disease: the difference between children and adults","volume":"14","author":"Kelsen","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.biopha.2025.117824_bib16","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/MPG.0000000000003730","article-title":"Clinical course of very early-onset inflammatory bowel disease","volume":"76","author":"Cucinotta","year":"2023","journal-title":"J. Pedia Gastroenterol. Nutr."},{"issue":"3","key":"10.1016\/j.biopha.2025.117824_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030969","article-title":"Pharmacologic management of monogenic and very early onset inflammatory bowel diseases","volume":"15","author":"Levine","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.117824_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113901","article-title":"DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease","volume":"157","author":"Selvestrel","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"6","key":"10.1016\/j.biopha.2025.117824_bib19","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/MIB.0000000000001099","article-title":"Management of inflammatory bowel disease in the elderly patient: challenges and opportunities","volume":"23","author":"Ananthakrishnan","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"issue":"11","key":"10.1016\/j.biopha.2025.117824_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.crohns.2014.05.006","article-title":"ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature","volume":"8","author":"Duricova","year":"2014","journal-title":"J. Crohns Colitis"},{"issue":"8","key":"10.1016\/j.biopha.2025.117824_bib21","article-title":"Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn's disease","volume":"21","author":"Krupoves","year":"2011","journal-title":"Pharm. Genom."},{"issue":"35","key":"10.1016\/j.biopha.2025.117824_bib22","doi-asserted-by":"crossref","first-page":"6385","DOI":"10.3748\/wjg.v23.i35.6385","article-title":"Time to clinical response and remission for therapeutics in inflammatory bowel diseases: what should the clinician expect, what should patients be told?","volume":"23","author":"Vasudevan","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2025.117824_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248905","article-title":"DNA hypo-methylation facilitates anti-inflammatory responses in severe ulcerative colitis","volume":"16","author":"Taman","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biopha.2025.117824_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/MCG.0b013e3181e8ae93","article-title":"Genetic predictors of glucocorticoid response in pediatric patients with inflammatory bowel diseases","volume":"45","author":"De Iudicibus","year":"2011","journal-title":"J. Clin. Gastroenterol."},{"issue":"12","key":"10.1016\/j.biopha.2025.117824_bib25","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1111\/j.1600-6143.2006.01553.x","article-title":"Differential effects of immunosuppressive drugs on T-cell motility","volume":"6","author":"Datta","year":"2006","journal-title":"Am. J. Transpl."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225000186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:52:10Z","timestamp":1762311130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225000186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"alternative-id":["S0753332225000186"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117824","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NLRP3 promoter methylation as a predictive biomarker for glucocorticoid response in patients with inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117824","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117824"}}